Economic Impact of PromarkerD In Vitro Diagnostic Testing on the Management of Chronic Kidney Disease in Type 2 Diabetes: A Budget Impact Analysis
{{output}}
Objectives: This study evaluated the clinical and economic impact of integrating Promarker®D, a validated biomarker-based blood test that predicts kidney function decline up to 4 years before clinical evidence of chronic kidney ... ...
